Anti-Smad3 antibody - ChIP Grade (ab28379)

ab28379 has been referenced in 20 publications.

1. Zhou B et al. Interactions Between ß-Catenin and Transforming Growth Factor-ß Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-activator cAMP-response Element-binding Protein (CREB)-binding Protein (CBP). J Biol Chem 287:7026-38 (2012). WB, ICC/IF, ChIP; Rat. PubMed: 22241478
2. van de Laar IM et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121-6 (2011). IHC-P; Human. PubMed: 21217753
3. Gressner OA et al. Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein. World J Gastroenterol 17:151-63 (2011). WB; Rat. PubMed: 21245987
4. Xu Y et al. Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes. Mol Biol Cell 21:29-35 (2010). ChIP; Human. PubMed: 19864455
5. Masszi A et al. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J Cell Biol 188:383-99 (2010). WB; Human. PubMed: 20123992
6. Wang FE et al. MicroRNA-204/211 alters epithelial physiology. FASEB J : (2010). WB; Human. PubMed: 20056717
7. Cunningham MF et al. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration. Am J Physiol Gastrointest Liver Physiol 299:G457-66 (2010). WB; Human. PubMed: 20489045
8. Andrianifahanana M et al. ERBB receptor activation is required for profibrotic responses to transforming growth factor beta. Cancer Res 70:7421-30 (2010). WB; Human. PubMed: 20841477
9. Maioli M et al. Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells. PLoS One 5:e15151 (2010). WB, ICC/IF; Human, Mouse. PubMed: 21152044
10. Fu Y et al. Differential regulation of transforming growth factor {beta} signaling pathways by notch in human endothelial cells. J Biol Chem 284:19452-62 (2009). ChIP, IF; Mouse. PubMed: 19473993
11. Luo DD et al. Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling. Nephrol Dial Transplant 24:2655-65 (2009). PubMed: 19420104
12. Minoo P et al. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains. Nucleic Acids Res 36:179-88 (2008). WB. PubMed: 18003659
13. Carlson ME et al. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454:528-32 (2008). WB; Mouse. PubMed: 18552838
14. Diamond ME et al. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci 121:2197-207 (2008). WB; Human. PubMed: 18544635
15. Bhaskaran M et al. Trans-differentiation of alveolar epithelial type II cells to type I cells involves autocrine signaling by transforming growth factor beta 1 through the Smad pathway. J Biol Chem 282:3968-76 (2007). PubMed: 17158884
16. Calon A et al. Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation. Gut 56:1688-95 (2007). PubMed: 17595234
17. Levy L et al. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27:6068-83 (2007). WB; Human. PubMed: 17591695
18. Zhang M et al. Polarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-catenin. J Biol Chem 282:28639-47 (2007). IP; Human. PubMed: 17623674
19. Gupta A et al. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442:82-5 (2006). PubMed: 16738545
20. Li L et al. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol 7:1157-65 (2006). PubMed: 17013388